-
The clinical trial results of compound artemisinin piperaquine tablets (yuetekuai) of Chinese pharmaceutical companies in Comoros were good
Time of Update: 2014-12-13
Malaria has been endemic for a long time in Comoros, a poor island country on the east coast of Africa This disease can lead to high fever, systemic pain, and very few deaths from cerebral malaria Thi
-
Study on 16 years hepatitis B vaccine of Jiachen bio, a subsidiary of Chongqing beer
Time of Update: 2014-12-13
According to the announcement, in view of the fact that the development of new drugs has the characteristics of high risk, high investment, strong professionalism and long cycle, as well as consultat
-
Application for clinical acceptance of kabalatin heavy tartrate tablets, a new Alzheimer's drug of Jingxin Pharmaceutical Co., Ltd
Time of Update: 2014-12-12
According to the information on the website of the State Food and Drug Administration (CFDA), the application of kabalatin tartrate tablets from Beijing New Pharmaceutical Co., Ltd has been accepted c
-
Wuhan Jianmin 5 traditional Chinese medicine kaiyuning tablet has not been approved before the second application for production
Time of Update: 2014-12-12
According to the public information of the State Food and Drug Administration (CFDA), the application for production of five kinds of traditional Chinese medicine kaiyuning tablets and its raw materia
-
Potassium acetate, a new class 3 drug of HISCO, will enter the site for inspection
Time of Update: 2014-12-12
According to the website of the State Food and Drug Administration (CFDA), the three kinds of new drug potassium acetate of Hisilicon will enter the site for inspection, which means that the drug only
-
Next year, we will launch a comprehensive post marketing reevaluation program
Time of Update: 2014-12-11
"Post market re evaluation is a general trend Enterprises should attach great importance to it, establish advanced concept of continuous innovation of old products, conduct product sorting, diagnosis
-
The production approval document of the new gastroulcer drug polyprizine granules of HISCO in about 3 months
Time of Update: 2014-12-09
According to the website of the State Food and Drug Administration (CFDA) on December 9, the status of the three digestive drugs of Hisilicon polyprizine granules changed to "under approval", which me
-
New drug 1.1 of enwaside Pharmaceutical Co., Ltd. is applied for production again
Time of Update: 2014-12-09
According to the information on the website of CFDA on December 9, the application and production of class 1.1 new drug etakalin hydrochloride raw materials and tablets of Jiangsu Enhua saide Pharmace
-
Transnational new drugs lag in "three reports and three batches" domestic innovative drugs still need to be accelerated
Time of Update: 2014-12-08
Recently, in the medical circle, the word "three newspapers and three batches" has been widely spread According to industry insiders, since June this year, pharmaceutical companies have found that the
-
Domestic entecavir declared to build up the market and fought miserably
Time of Update: 2014-12-08
In terms of drug sales ranking of sample hospitals, entecavir ranked 27th in 2012, 15th in 2013, up 12 places, and has become the core product of nucleoside antiviral drugs China is a country with fre
-
Unveiling of the eighth "Wuxi apptec prize for biochemical research"
Time of Update: 2014-12-08
Winner of outstanding achievement award of the 8th Pharmaceutical Research Award: Qiao Jie, Dean of the Third Hospital of Peking University, researcher of Shanghai Pharmaceutical Research Institute of
-
Wuzhong, Jiangsu Province, raised 500 million yuan to invest in a class of anticancer drugs
Time of Update: 2014-12-08
In just two weeks, the stock market of Shanghai and Shenzhen ushered in another round of big ups and downs When the securities companies, banks and real estate stocks were in a frenzy, pharmaceutical
-
The first new drug imitated by esomeprazole of Laimei Pharmaceutical Co., Ltd. will be on the market soon
Time of Update: 2014-12-05
It is understood that digestive tract ulcer is a common digestive system disease, the incidence rate is 10%-12% in China, and some areas are as high as 28% Esomeprazole is a new generation of proton p
-
November 2014 CDE drug review report
Time of Update: 2014-12-05
Key points: East Sunshine new report in 2014, class 1.1 anti hepatitis C drug, imitavir, has been approved by the Academy of clinical military sciences to declare the proposed anti Ebola drug, fabilav
-
Great progress has been made in the clinical trials of youxinding capsule, a new Chinese medicine class 1 drug, of Shanghai innovation and research center of traditional Chinese Medicine
Time of Update: 2014-12-05
The kick-off training meeting of "phase Ⅱ a clinical trial of youxinding capsule - multicenter, randomized, double-blind, placebo parallel control, dose exploration clinical trial, evaluation of the s
-
Domestic anti AIDS drugs catch up
Time of Update: 2014-12-04
December 1 is the 27th World AIDS Day, and the theme of this year's event is still "get up and move towards zero aids - gather strength, overcome difficulties and control AIDS" Zero) is intended to sh
-
Check the first imitated drugs and exclusive varieties in China
Time of Update: 2014-12-04
The following are some core varieties in the field of domestic medicine: first generic Series 1 Hengrui medicine: oxaliplatin, docetaxel, irinotecan; 2 Enhua medicine: ziprasidone, the original manufa
-
Application for production acceptance of zatoribuprofen, a class 3.1 new drug of Asia Pacific pharmaceutical
Time of Update: 2014-12-02
Zatoibuprofen was developed jointly by Chemiphar and zeria company in Japan It was first listed in Japan in 1993 It can selectively act on the inflammatory site, but has no effect on the stomach and k
-
Wenzhou Medical University signed a technology transfer contract of 10 million yuan with Anke biology
Time of Update: 2014-12-02
On November 22, Wenzhou Medical University and Anhui Anke Bioengineering (Group) Co., Ltd held a signing ceremony of new drug technology transfer The new generation of thermosensitive gel of fibroblas
-
Two class 1.1 innovative drugs in Jiangsu Province have been approved for listing this year
Time of Update: 2014-12-02
The two innovative drugs of 1.1 class were apatinib mesylate, a new anti gastric cancer drug of Hengrui medicine, and moroxynidazole, an anti infection drug of hausen medicine These two new drugs have
